Abstract:Background: Hepatitis B virus (HBV) infection is considered as an independent risk factor for poor prognosis in hepatocellular carcinoma (HCC) patients, but the molecular mechanisms have not been fully elucidated. Ectonucleotide pyrophosphatase-phosphodiesterase 2 (ENPP2) hydrolyzes lysophosphatidylcholine (LPC) to produce lysophosphatidic acid (LPA) and participates in virus replication and tumor progress. This study aimed to elucidate whether HBV infection inducing HCC progression via LPC/ENPP2/LPA axis. Methods: The clinical data for HCC patients were collected and prognosis was analyzed. The in vitro and in vivo experiments were used to investigate the influences of HBV, ENPP2 and activated hepatic stellate cell (HSC) on HCC progression. Findings: We found that ENPP2 expression was positively related to HBV infection and poor prognosis. HBV-induced HCC progression via ENPP2 was enhanced by LPC which was secreted by activated HSC. HCC patients with high ENPP2 combined with cirrhosis had worse prognosis than non-cirrhotic patients. In cirrhotic HCC patients, high ENPP2 expression cohort also had worse prognosis than low expression cohort. Interpretation: In HBV positive cirrhotic HCC patients, HBV enhanced host cell secretion of ENPP2, combined with LPC secreted by fibroblast to promote tumor progression via LPC/ENPP2/LPA. These findings may provide insights into novel approaches to HBV associated HCC therapy. Funding Statement: This study was supported by the National Natural Science Foundation of China (81801999, 81772597, 81672412, 81972255), the Guangdong Science and Technology Foundation (2017A030311002), the Science Foundation of Jiangxi (20181BAB214002), the Education Department Science and Technology Foundation of Jiangxi (GJJ170936) and grant from Guangdong Science and Technology Department (2017B030314026). Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: The clinicopathologic information of HCC patient (n = 774) and tumor tissues (n = 158) were obtained from Sun Yat-sen Memorial Hospital after approval by the hospital Ethical Committee. Animal studies were carried out in the South China University of Technology and approved by the Laboratory Animal Welfare and Ethics Committee of the South China University of Technology. All animal experiments conformed to the approved guidelines of Animal Care and Use Committee of South China University of Technology.

Hepatitis B Virus PreS1 Facilitates Hepatocellular Carcinoma Development by Promoting Appearance and Self-Renewal of Liver Cancer Stem Cells.

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Hepatitis B Virus Large Surface Antigen Promotes Tumorigenesis of Human Hepatocellular Carcinoma Cells through Activating Src / PI 3 K / Akt Pathway

Hepatitis B Virus X Protein in the Proliferation of Hepatocellular Carcinoma Cells

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling

C-terminal Truncated Hepatitis B Virus X Protein Promotes Hepatocellular Carcinogenesis Through Induction of Cancer and Stem Cell-Like Properties.

HBV Pres Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Up-Regulating Inflammatory Signaling

Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein

Hepatitis B virus X protein promotes the stem-like properties of OV6 + cancer cells in hepatocellular carcinoma

Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42

Hepatocellular Carcinoma Progression Mediated by Hepatitis B Virus-Encoded Circrna HBV_circ_1 Through Interaction with CDK1

Hepatitis B Virus Protein Pres2 Potentially Promotes Hcc Development Via Its Transcriptional Activation of Htert

Hepatitis B Virus Infection Promotes Hepatocellular Carcinoma Progression Through LPC/ENPP2/LPA Axis

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Interaction of Lhbs with C53 Promotes Hepatocyte Mitotic Entry: A Novel Mechanism for Hbv-Induced Hepatocellular Carcinoma

HBV Pres2 Transactivates FOXP3 Expression in Malignant Hepatocytes

Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells via Facilitating the Expression and Secretion of ENPP2

Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma

Effects of Hepatitis B Virus X Protein on the Development of Liver Cancer